42.0.0.26 – Redirect Fix (Removed pre-redirect output)
DEBUG LOG – klik om te openen
=== VARIABELEN ===
Array
(
[defid] => VWS-WOO-08b-1368177
[request_id] =>
)
=== SQL LOG ===
Geen SQL queries.
Huidig document record
Array
(
[id] => bf89f646-1e8d-4fac-8f8f-124a2a67bf18
[Document ID] => 1368177
[Document naam] => Summary table phase 3 trials COVID-19 vaccine candidates_infogezondheidsraad.docx
[Bestandsnaam] =>
[Beoordeling] =>
[Beoordelingsgrond] =>
[Toelichting] =>
[Publieke link] =>
[Locatie open.minvws.nl] => https://open.minvws.nl/dossier/VWS-WOO/3755967-1060180-pdo/document/VWS-WOO-08b-1368177
[Opgeschort] =>
[Definitief ID] => VWS-WOO-08b-1368177
[Status] => shiningstar
[FromFile] => https://open.minvws.nl/dossier/VWS-WOO/3755967-1060180-pdo
[DocumentPublicationDate] => 2 oktober 2020
[DocumentStatusCheckedDate] => 2026-04-29 03:59:27.874696
[DocumentStatusCheckedResult] => 200
[SourceFileType] =>
[Tags] =>
[Besluit] =>
[ModifiedDate] => 2025-09-22 09:42:08
[DeletedDate] =>
[BesluitURL] =>
[CreatedDate] => 2025-06-19 18:31:59
[DocumentDownloadLink] =>
[DigestLaatsteControleDatum] => 2025-09-22 09:42:08
)
Document: VWS-WOO-08b-1368177
Klik om te vergroten
Document correcties
Geregistreerde datum: 20201002
Geregistreerde documentnaam: Summary table phase 3 trials COVID-19 vaccine candidates_infogezondheidsraad.docx
Document attributen
| Tag | Waarde | Datum |
|---|---|---|
| About_Gelakte gegevens | 5.1.2e Eerbiediging van de persoonlijke levenssfeer Komt u in dit document gegevens tegen waarvan u denkt dat deze gelakt hadden moeten worden? Of is het document slecht leesbaar? Laat het ons weten | 2025-09-01 16:20:56 |
| About_Gelakte gegevens_linkhref_2 | mailto:DienstpostbusDatalekkenDoo@minvws.nl | 2025-09-01 16:20:56 |
| DocumentDownload_linkname | Download (pdf, 790.84 KB) | 2025-07-10 19:19:30 |
| DocumentDownload_linkhref | https://open.minvws.nl/dossier/VWS-WOO/3755967-1060180-pdo/file/download/document/1ef0927a-0670-618a-a77a-cb1f2dce5f23 | 2025-07-10 19:19:30 |
| DocumentDownload_proposed_filename (lokale kopie) | VWS-WOO-08b-1368177.pdf | 2025-07-10 19:19:30 |
| document_SectionDownloadButton | 1 | 2025-07-10 19:19:30 |
| document_SectionHTMLDataDivs | 2 | 2025-06-22 23:51:05 |
| document_SectionAbout | 1 | 2025-06-22 23:51:05 |
| About_Datum document | 2 oktober 2020 | 2025-06-22 23:51:05 |
| About_Type bronbestand | Word-document, 2 pagina's | 2025-06-22 23:51:05 |
| About_Type bronbestand_paginas | 2 | 2025-06-22 23:51:05 |
| About_Download als | PDF (790.84 KB) | 2025-06-22 23:51:05 |
| About_Documentnummer | 1368177 | 2025-06-22 23:51:05 |
| About_Beoordeling | Gedeeltelijke openbaarmaking | 2025-06-22 23:51:05 |
| About_Gelakte gegevens | 5.1.2e Eerbiediging van de persoonlijke levenssfeer Komt u in dit document gegevens tegen waarvan u denkt dat deze gelakt hadden moeten worden? Of is het document slecht leesbaar? Laat het ons weten. | 2025-06-22 23:51:05 |
| About_Gelakte gegevens_linkhref_1 | https://wetten.overheid.nl/BWBR0045754/2022-08-01#Hoofdstuk5 | 2025-06-22 23:51:05 |
| About_Gelakte gegevens_linkname_1 | 5.1.2e Eerbiediging van de persoonlijke levenssfeer | 2025-06-22 23:51:05 |
| About_Gelakte gegevens_linkhref_2 | mailto:_dienstpostbusWoo-corona-ondersteuning@minvws.nl?subject=Opmerking over Summary table phase 3 trials COVID-19 vaccine candidates_infogezondheidsraad.docx (documentnummer 1ef0927a-0670-618a-a77a-cb1f2dce5f23) | 2025-06-22 23:51:05 |
| About_Gelakte gegevens_linkname_2 | Laat het ons weten | 2025-06-22 23:51:05 |
| document_SectionRequest | 1 | 2025-06-22 23:51:05 |
| Request_Onderdeel van | Woo-deelbesluit aangaande Vaccinaties en Medicatie over Vaccinaties | 2025-06-22 23:51:05 |
| Request_Onderdeel van_linkhref_1 | https://open.minvws.nl/dossier/VWS-WOO/3755967-1060180-pdo | 2025-06-22 23:51:05 |
| Request_Onderdeel van_linkname_1 | Woo-deelbesluit aangaande Vaccinaties en Medicatie over Vaccinaties | 2025-06-22 23:51:05 |
| Request_Samenvatting verzoek | De minister van Volksgezondheid, Welzijn en Sport heeft op 29 februari 2024 een besluit genomen op verzoeken in het kader van de Wet open overheid. Het besluit betreft openbaarmaking van documenten die betrekking hebben op informatie aangaande Cluster Vaccinaties en Medicatie. | 2025-06-22 23:51:05 |
| Request_Periode | Januari 2020 t/m maart 2023 | 2025-06-22 23:51:05 |
| Request_Type besluit | Woo-besluit | 2025-06-22 23:51:05 |
| Request_Datum besluit | 29 februari 2024 | 2025-06-22 23:51:05 |
| Request_Omvang openbaarmaking | 6.493 documenten, 23.875 pagina's Inventarislijst | 2025-06-22 23:51:05 |
| Request_Omvang openbaarmaking_documenten | 6.493 | 2025-06-22 23:51:05 |
| Request_Omvang openbaarmaking_paginas | 23.875 | 2025-06-22 23:51:05 |
| Request_Omvang openbaarmaking_linkhref_1 | https://open.minvws.nl/dossier/VWS-WOO/3755967-1060180-pdo/file/download/inventory | 2025-06-22 23:51:05 |
| Request_Omvang openbaarmaking_linkname_1 | Inventarislijst | 2025-06-22 23:51:05 |
| document_documentName | Summary table phase 3 trials COVID-19 vaccine candidates_infogezondheidsraad.docx | 2025-06-22 23:51:05 |
| document_documentType | Word-document | 2025-06-22 23:51:05 |
| document_documentPublicationDate | 2020-10-02 | 2025-06-22 23:51:05 |
| document_documentNumber | VWS-WOO-08b-1368177 | 2025-06-22 23:51:05 |
| document_SectionDownloadButton | 0 | 2025-06-22 23:51:05 |
Archiefversies (9 rijen)
Archiefrij 1 — 2025-11-21 15:49:28
fromFile: VWS-WOO-3755967-1060180-pdo-1f0a50a6-cb61-6ff8-8b0f-91d3fb5eede4.zip
fromFilePath: archieven_files\VWS-WOO-3755967-1060180-pdo-1f0a50a6-cb61-6ff8-8b0f-91d3fb5eede4.zip
documentName: VWS-WOO-08b-1368177.pdf
documentType: pdf
documentCompressedSize: 437706
documentSize: 809819
documentCompressRatio: 54.04985558501344
documentDateModified: 2025-10-09 12:28:06
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-11-21 15:49:28
lastSeen: 2025-11-21 15:49:28
text: 1368177
Details phase 3 trials COVID-19 vaccine candidates
Vaccine
AstraZeneca
Moderna
Pfizer/BioNtech
Janssen
Sanofi
CureVac
AZD1222
mRNA-1273
BNT162b2 RNA
Ad26.COV2.S
preS dTM
cVnCoV
5x10 vp
100 ug
30ug
5x10% vp
5ug
Protein subunit
Platform
Control
administration
Viral vector
...
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: leeg!
documentMailAdresses: leeg!
digestSHA256: 9755001338ef8bdd39252e30c7da86a3a0e0ebd4fa4b89eb38e44e1133aa38de
documentDate: leeg!
ModifiedDate: 2025-12-10 19:42:10.749631+00
Id: 43e2a9fd-f23a-4e95-9fc4-4d6b86845894
textDigestSHA256: 7703f5ef79f3183e4891728ec9c3a0860182d7bb9d84bb299c72c251e1c2a461
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-08b-1368177
Archiefrij 2 — 2025-11-21 15:46:06
fromFile: VWS-WOO-3755967-1060180-pdo-1f026c98-b5e5-6728-804f-65673e0af118.zip
fromFilePath: archieven_files\VWS-WOO-3755967-1060180-pdo-1f026c98-b5e5-6728-804f-65673e0af118.zip
documentName: VWS-WOO-08b-1368177.pdf
documentType: pdf
documentCompressedSize: 437706
documentSize: 809819
documentCompressRatio: 54.04985558501344
documentDateModified: 2025-10-09 12:28:06
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-11-21 15:46:06
lastSeen: 2025-11-21 15:46:06
text: 1368177
Details phase 3 trials COVID-19 vaccine candidates
Vaccine
AstraZeneca
Moderna
Pfizer/BioNtech
Janssen
Sanofi
CureVac
AZD1222
mRNA-1273
BNT162b2 RNA
Ad26.COV2.S
preS dTM
cVnCoV
5x10 vp
100 ug
30ug
5x10% vp
5ug
Protein subunit
Platform
Control
administration
Viral vector
...
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: leeg!
documentMailAdresses: leeg!
digestSHA256: 9755001338ef8bdd39252e30c7da86a3a0e0ebd4fa4b89eb38e44e1133aa38de
documentDate: leeg!
ModifiedDate: 2025-12-10 19:41:04.555019+00
Id: b6500e48-68af-4364-a4c0-8f74c8b2f60d
textDigestSHA256: 7703f5ef79f3183e4891728ec9c3a0860182d7bb9d84bb299c72c251e1c2a461
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-08b-1368177
Archiefrij 3 — 2025-09-07 17:19:11
fromFile: folder_import
fromFilePath: /volume3/websites/openrijksoverheid/documenten_files/VWS-WOO-08b-1368177.pdf
documentName: VWS-WOO-08b-1368177.pdf
documentType: pdf
documentCompressedSize: 0
documentSize: 809819
documentCompressRatio: 0
documentDateModified: 2025-09-08 16:14:37
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-09-07 17:19:11
lastSeen: 2025-09-08 16:14:37
text: Details phase 3trials COVID-19 vaccine candidates
AstraZeneca Moderna Pfizer/BioNtech JanssenSanofiCureVac
VaccineAZD1222 mRNA-1273 BNT162b2 RNA Ad26.COV2.S preS dTM cVnCoV
5x10" vp 100 ug 30ug 5x10% vp 5ug
PlatformViral vector mRNA mRNA Viral Vector Protein subunit|mRNA
Controlsaline saline saline ...
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: leeg!
documentMailAdresses: leeg!
digestSHA256: 9755001338ef8bdd39252e30c7da86a3a0e0ebd4fa4b89eb38e44e1133aa38de
documentDate: leeg!
ModifiedDate: 2025-12-10 19:41:04.555019+00
Id: folder_import_11676_956972bd8eee01d4087209da2d792ce7
textDigestSHA256: bb01384186d51c60c5709ec655584b04dea3d6682fcdddef667aca0c9883b1a3
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-08b-1368177
Archiefrij 4 — 2025-09-04 17:16:09
fromFile: VWS-WOO-3755967-1060180-pdo-1f026c98-b5e5-6728-804f-65673e0af118.1.zip
fromFilePath: ../../archieven_files/VWS-WOO-3755967-1060180-pdo-1f026c98-b5e5-6728-804f-65673e0af118.1.zip
documentName: VWS-WOO-08b-1368177.pdf
documentType: pdf
documentCompressedSize: 437706
documentSize: 809819
documentCompressRatio: 54.04985558501344
documentDateModified: 2025-05-01 20:43:50
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-09-04 17:16:09
lastSeen: 2025-11-21 13:47:41
text: Details phase 3trials COVID-19 vaccine candidates
AstraZeneca Moderna Pfizer/BioNtech JanssenSanofiCureVac
VaccineAZD1222 mRNA-1273 BNT162b2 RNA Ad26.COV2.S preS dTM cVnCoV
5x10" vp 100 ug 30ug 5x10% vp 5ug
PlatformViral vector mRNA mRNA Viral Vector Protein subunit|mRNA
Controlsaline saline saline ...
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: leeg!
documentMailAdresses: leeg!
digestSHA256: 9755001338ef8bdd39252e30c7da86a3a0e0ebd4fa4b89eb38e44e1133aa38de
documentDate: leeg!
ModifiedDate: 2025-12-10 19:42:20.178639+00
Id: VWS-WOO-3755967-1060180-pdo-1f026c98-b5e5-6728-804f-65673e0af118.zip_2191
textDigestSHA256: bb01384186d51c60c5709ec655584b04dea3d6682fcdddef667aca0c9883b1a3
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-08b-1368177
Archiefrij 5 — 2025-03-21 07:59:42
fromFile: 2024.075-VWS-WOO-3755967-1060180-pdo.zip
fromFilePath: Z:\ARCHIEF WOO Documenten\archieven_files\2024.075-VWS-WOO-3755967-1060180-pdo.zip
documentName: VWS-WOO-08b-1368177-Summary_table_phase_3_trials_COVID-19_vaccine_candidates_infogezondheidsraad.docx.pdf
documentType: pdf
documentCompressedSize: 436609
documentSize: 809819
documentCompressRatio: 53.9143932162619
documentDateModified: 2024-10-30 14:23:56
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-03-21 07:59:42
lastSeen: 2025-03-21 07:59:42
text: Details phase 3trials COVID-19 vaccine candidates
AstraZeneca Moderna Pfizer/BioNtech JanssenSanofiCureVac
VaccineAZD1222 mRNA-1273 BNT162b2 RNA Ad26.COV2.S preS dTM cVnCoV
5x10" vp 100 ug 30ug 5x10% vp 5ug
PlatformViral vector mRNA mRNA Viral Vector Protein subunit|mRNA
Controlsaline saline saline ...
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: leeg!
documentMailAdresses: leeg!
digestSHA256: bb01384186d51c60c5709ec655584b04dea3d6682fcdddef667aca0c9883b1a3
documentDate: leeg!
ModifiedDate: 2025-12-10 19:40:42.137456+00
Id: 395790
textDigestSHA256: bb01384186d51c60c5709ec655584b04dea3d6682fcdddef667aca0c9883b1a3
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-08b-1368177
Archiefrij 6 — 2025-03-18 09:30:27
fromFile: 2023.022-VWS-WOO-3755967-1060180-pdo.zip
fromFilePath: Z:\ARCHIEF WOO Documenten\archieven_files\2023.022-VWS-WOO-3755967-1060180-pdo.zip
documentName: VWS-WOO-08b-1368177-Summary_table_phase_3_trials_COVID-19_vaccine_candidates_infogezondheidsraad.docx.pdf
documentType: pdf
documentCompressedSize: 436609
documentSize: 809819
documentCompressRatio: 53.9143932162619
documentDateModified: 2024-10-30 14:23:56
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-03-18 09:30:27
lastSeen: 2025-03-18 09:30:27
text: Details phase 3trials COVID-19 vaccine candidates
AstraZeneca Moderna Pfizer/BioNtech JanssenSanofiCureVac
VaccineAZD1222 mRNA-1273 BNT162b2 RNA Ad26.COV2.S preS dTM cVnCoV
5x10" vp 100 ug 30ug 5x10% vp 5ug
PlatformViral vector mRNA mRNA Viral Vector Protein subunit|mRNA
Controlsaline saline saline ...
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: leeg!
documentMailAdresses: leeg!
digestSHA256: bb01384186d51c60c5709ec655584b04dea3d6682fcdddef667aca0c9883b1a3
documentDate: leeg!
ModifiedDate: 2025-12-10 19:42:20.178639+00
Id: 371442
textDigestSHA256: bb01384186d51c60c5709ec655584b04dea3d6682fcdddef667aca0c9883b1a3
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-08b-1368177
Archiefrij 7 — 2025-02-27 09:25:07
fromFile: 2023.031-VWS-WOO-3755967-1060180-pdo.zip
fromFilePath: Z:\ARCHIEF WOO Documenten\archieven_files\2023.031-VWS-WOO-3755967-1060180-pdo.zip
documentName: VWS-WOO-08b-1368177-Summary_table_phase_3_trials_COVID-19_vaccine_candidates_infogezondheidsraad.docx.pdf
documentType: pdf
documentCompressedSize: 436609
documentSize: 809819
documentCompressRatio: 53.9143932162619
documentDateModified: 2024-10-30 14:23:56
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-02-27 09:25:07
lastSeen: 2025-02-27 09:25:07
text: Details phase 3trials COVID-19 vaccine candidates
AstraZeneca Moderna Pfizer/BioNtech JanssenSanofiCureVac
VaccineAZD1222 mRNA-1273 BNT162b2 RNA Ad26.COV2.S preS dTM cVnCoV
5x10" vp 100 ug 30ug 5x10% vp 5ug
PlatformViral vector mRNA mRNA Viral Vector Protein subunit|mRNA
Controlsaline saline saline ...
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: leeg!
documentMailAdresses: leeg!
digestSHA256: bb01384186d51c60c5709ec655584b04dea3d6682fcdddef667aca0c9883b1a3
documentDate: leeg!
ModifiedDate: 2025-12-10 19:41:04.555019+00
Id: 284613
textDigestSHA256: bb01384186d51c60c5709ec655584b04dea3d6682fcdddef667aca0c9883b1a3
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-08b-1368177
Archiefrij 8 — 2025-02-27 09:25:00
fromFile: 2023.011-VWS-WOO-3755967-1060180-pdo.zip
fromFilePath: Z:\ARCHIEF WOO Documenten\archieven_files\2023.011-VWS-WOO-3755967-1060180-pdo.zip
documentName: VWS-WOO-08b-1368177-Summary_table_phase_3_trials_COVID-19_vaccine_candidates_infogezondheidsraad.docx.pdf
documentType: pdf
documentCompressedSize: 436609
documentSize: 809819
documentCompressRatio: 53.9143932162619
documentDateModified: 2024-10-30 14:23:56
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-02-27 09:25:00
lastSeen: 2025-02-27 09:25:00
text: Details phase 3trials COVID-19 vaccine candidates
AstraZeneca Moderna Pfizer/BioNtech JanssenSanofiCureVac
VaccineAZD1222 mRNA-1273 BNT162b2 RNA Ad26.COV2.S preS dTM cVnCoV
5x10" vp 100 ug 30ug 5x10% vp 5ug
PlatformViral vector mRNA mRNA Viral Vector Protein subunit|mRNA
Controlsaline saline saline ...
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: leeg!
documentMailAdresses: leeg!
digestSHA256: bb01384186d51c60c5709ec655584b04dea3d6682fcdddef667aca0c9883b1a3
documentDate: leeg!
ModifiedDate: 2025-12-10 19:41:04.555019+00
Id: 193558
textDigestSHA256: bb01384186d51c60c5709ec655584b04dea3d6682fcdddef667aca0c9883b1a3
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-08b-1368177
Archiefrij 9 — 2025-02-18 12:18:04
fromFile: Besluit__dossier_nr_-2ddff5cf6308781f1485177c04b12fc0a19bb773f8e1b2f357c77b148697d12a.zip
fromFilePath: Z:\ARCHIEF WOO Documenten\archieven_files\Besluit__dossier_nr_-2ddff5cf6308781f1485177c04b12fc0a19bb773f8e1b2f357c77b148697d12a.zip
documentName: VWS-WOO-08b-1368177-Summary_table_phase_3_trials_COVID-19_vaccine_candidates_infogezondheidsraad.docx.pdf
documentType: pdf
documentCompressedSize: 436609
documentSize: 809819
documentCompressRatio: 53.9143932162619
documentDateModified: 2024-10-30 14:23:56
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-02-18 12:18:04
lastSeen: 2025-02-18 12:18:04
text: Details phase 3trials COVID-19 vaccine candidates
AstraZeneca Moderna Pfizer/BioNtech JanssenSanofiCureVac
VaccineAZD1222 mRNA-1273 BNT162b2 RNA Ad26.COV2.S preS dTM cVnCoV
5x10" vp 100 ug 30ug 5x10% vp 5ug
PlatformViral vector mRNA mRNA Viral Vector Protein subunit|mRNA
Controlsaline saline saline ...
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: leeg!
documentMailAdresses: leeg!
digestSHA256: bb01384186d51c60c5709ec655584b04dea3d6682fcdddef667aca0c9883b1a3
documentDate: leeg!
ModifiedDate: 2025-12-10 19:40:42.137456+00
Id: 73708
textDigestSHA256: bb01384186d51c60c5709ec655584b04dea3d6682fcdddef667aca0c9883b1a3
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-08b-1368177
(dit is ook een speeltuin)